Screening of synthetic and plant-derived compounds for (anti)estrogenic and (anti)androgenic activities

被引:74
作者
Bovee, Toine F. H. [1 ]
Schoonen, Willem G. E. J. [2 ]
Hamers, Astrid R. M. [1 ]
Bento, Marta Jorge [1 ]
Peijnenburg, Ad A. C. M. [1 ]
机构
[1] RIKILIT Inst Food Safety, Dept Safety & Hlth, NL-6700 AE Wageningen, Netherlands
[2] NV Organon, Dept Pharmacol, NL-5340 BH Oss, Netherlands
关键词
agonist; antagonist; plant hormones; synthetic antiestrogens; yeast estrogen bioassay; yeast androgen bioassay;
D O I
10.1007/s00216-007-1772-3
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Recently we constructed yeast cells that either express the human estrogen receptor alpha or the human androgen receptor in combination with a consensus ERE or ARE repeat in the promoter region of a green fluorescent protein (yEGFP) read-out system. These bioassays were proven to be highly specific for their cognate agonistic compounds. In this study the value of these yeast bioassays was assessed for analysis of compounds with antagonistic properties. Several pure antagonists, selective estrogen receptor modulators (SERMs) and plant-derived compounds were tested. The pure antiestrogens ICI 182,780 and RU 58668 were also classified as pure ER antagonists in the yeast estrogen bioassay and the pure antiandrogen flutamide was also a pure AR antagonist in the yeast androgen bioassay. The plant-derived compounds flavone and guggulsterone displayed both antiestrogenic and antiandrogenic activities, while 3,3'-diindolylmethane (DIM) and equol combined an estrogenic mode of action with an antiandrogenic activity. Indol-3-carbinol (I3C) only showed an antiandrogenic activity. Coumestrol, genistein, naringenin and 8-prenylnaringenin were estrogenic and acted additively, while the plant sterols failed to show any effect. Although hormonally inactive, in vitro and in vivo metabolism of the aforementioned plant sterols may still lead to the formation of active metabolites in other test systems.
引用
收藏
页码:1111 / 1119
页数:9
相关论文
共 48 条
  • [21] Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 1. Receptor interactions
    Jordan, VC
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (06) : 883 - 908
  • [22] Juretic Antonio, 2006, Lijec Vjesn, V128, P31
  • [23] EFFECTS OF PROGESTAGENS AND ORG-OD14 IN IN-VITRO AND IN-VIVO TUMOR-MODELS
    KLOOSTERBOER, HJ
    SCHOONEN, WGEJ
    DECKERS, GH
    KLIJN, JGM
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1994, 49 (4-6) : 311 - 318
  • [24] Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta
    Kuiper, GGJM
    Carlsson, B
    Grandien, K
    Enmark, E
    Haggblad, J
    Nilsson, S
    Gustafsson, JA
    [J]. ENDOCRINOLOGY, 1997, 138 (03) : 863 - 870
  • [25] Plant-derived 3,3′-diindolylmethane is a strong androgen antagonist in human prostate cancer cells
    Le, HT
    Schaldach, CM
    Firestone, GL
    Bjeldanes, LF
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (23) : 21136 - 21145
  • [26] Leblanc K, 2007, INT J ONCOL, V30, P477
  • [27] Detection of estrogenic activity in sediment-associated compounds using in vitro reporter gene assays
    Legler, J
    Dennekamp, M
    Vethaak, AD
    Brouwer, A
    Koeman, JH
    van der Burg, B
    Murk, AJ
    [J]. SCIENCE OF THE TOTAL ENVIRONMENT, 2002, 293 (1-3) : 69 - 83
  • [28] In vivo implants of β-sitosterol cause reductions of reactive cholesterol pools in mitochondria isolated from gonads of male goldfish (Carassius auratus)
    Leusch, FDL
    MacLatchy, DL
    [J]. GENERAL AND COMPARATIVE ENDOCRINOLOGY, 2003, 134 (03) : 255 - 263
  • [29] Equol is a novel anti-androgen that inhibits prostate growth and hormone feedback
    Lund, TD
    Munson, DJ
    Haldy, ME
    Setchell, KDR
    Lephart, ED
    Handa, RJ
    [J]. BIOLOGY OF REPRODUCTION, 2004, 70 (04) : 1188 - 1195
  • [30] Inhibition of volume-regulated anion channels in cultured endothelial cells by the anti-oestrogens clomiphene and nafoxidine
    Maertens, C
    Droogmans, G
    Chakraborty, P
    Nilius, B
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2001, 132 (01) : 135 - 142